“Turbo-Cancer” in the Lung of Pope Leo XIV, a Promoter of COVID Vaccines
On Tuesday, October 13, Pope Leo XIV underwent surgery to remove a portion of his lung due to a tumor; in previous years, he had been a leading advocate of the COVID vaccination campaign, describing it as an “act of love.” Relying on information disseminated by the medical establishment, the then-bishop did not hesitate to spread the falsehood that mRNA Covid gene serums could limit transmission, a claim refuted from all quarters, most recently by the Florida Attorney General’s lawsuit against Pfizer, and previously by the authoritative journal *Science*.
Is there a faint possibility that, following his serious illness, a Christian like the current Pontiff—innately inclined to acknowledge and repent of his errors—might be ready to question the dangerous “Vaccine God” narrative?
This narrative was upheld by the Vatican to avoid defying the New World Order—comprising friends and profiteers of Big Pharma—during the SARS-CoV pandemic, a virus treacherously engineered in a laboratory.
If, as the Gospel states, Jesus Christ is the “way, the truth, and the life” (John 14:6), how do the Pope and the cardinals have the audacity to refrain from questioning the science to which they bowed?
Unfortunately for him, the Pope had to experience firsthand a highly probable adverse reaction to the very vaccines he had so imprudently and brazenly promoted
Autoimmune Pulmonary Conditions and “Turbo-Cancer”: Typical Adverse Reactions to Covid Vaccines
Yet, the health updates regarding Pope Leo XIV’s medical conditions echo with a sense of terrible nemesis, as they evoke two pathologies long listed among the most serious side effects of mRNA gene therapies:
Having made this long and inevitable preamble, let us look at what the Holy See’s official bulletin reports regarding the health issue facing the Bishop of Rome, Robert Francis Prevost.
Pope undergoes surgery at Gemelli; lower lobe of right lung removed
“In a procedure lasting approximately 90 minutes—which was successful and free of complications, Pope Leo XIV had the lower lobe of his right lung removed; an intraoperative histological examination confirmed a diagnosis of pulmonary adenocarcinoma. The anticipated medical bulletin containing news on Pope Leo’s health arrived in the evening at 9:53 PM (Occtober, 13), just over two hours after the surgery performed this afternoon, October 13, at the Gemelli Policlinic,” writes Vatican News.
The medical bulletin
“In the bulletin released by the Holy See Press Office, Dr. Luigi Carbone—Director of the Directorate of Health and Hygiene for Vatican City State—and Professor Margaritora announced: ‘This afternoon, the Holy Father underwent the scheduled thoracic surgery. To ensure a radical resection, the lower lobe of the right lung was removed using a video-assisted technique. An intraoperative histological examination confirmed the diagnosis of pulmonary adenocarcinoma, as had been suspected based on pre-operative tests,'” the Vatican news site adds.
“The Holy Father,” the statement continues, “was in the operating room for approximately three hours; the surgery itself lasted about 90 minutes. The procedure was successful, and there were no complications.”
Following the surgery, Leo XIV “woke up normally and, after a brief period of observation, returned to his room on the tenth floor.”
Fabio Giuseppe Carlo Carisio – Founder and Director of Gospa News
«She Believed in it with her whole heart. Dolly Parton’s hope for the genetic vaccine was as pure as anything she ever sang — and then her immune system turned on her, and a “brief battle” took her away».
The Mystery Behind the Form of Cancer That Affected the Singer
«Dolly Parton died Tuesday at Vanderbilt-Ingram Cancer Center in Nashville. She was 80. The estate’s official line — delivered first by a nephew in a recorded video, then repeated by publicist Marcel Pariseau and “Team Dolly” — is that she faced “a brief battle with cancer” and departed surrounded by loved ones» adds McCullough, referring to what was officially communicated by the singer’s entourage.
«In a statement to PEOPLE on Aug. 25, reps for the country star confirmed that the “Jolene” singer’s death at 80 on Tuesday followed a “brief battle with cancer.”The type of cancer was not disclosed» People wrote yesterday.
“Our beloved Dolly Parton spent her life and career bringing joy, laughter, hope and integrity into everything she touched. Her unmatched generosity reached the lives of countless people whom she would never meet, yet she was always there to offer a helping hand,” the statement read.
Autoimmune Damage Typically from Adverse Reactions to Covid Vaccine
«What type of cancer? Not disclosed. Hospitalized four days prior with, per one outlet, kidney and autoimmune issues. And that’s the whole story the public is getting» adds the American cardiologist, referring to the autoimmune disasters that represent one of the main causes of lethal adverse reactions to Covid mRNA genetic serums.
«For a woman worth a reported $600 million, with access to the absolute best medicine money can buy, the opacity is striking» highlights McCullough.
VIDEO – In 2021, Dolly Parton, a testimonial humming for the Covid-19 vaccine…
It’s disconcerting because, just over five years ago, in March 2021, she was the “testimonial” for the Covid-19 shot, appearing in a video circulated by mainstream media around the world while humming about the vaccine during the injection.
Trump declared National Mourning but he Defends Covid Vaccines which can Trigger Cancer
It’s even more disconcerting because one of her most famous fans, US President Donald Trump, wanted to honor her as a true star by declaring a week of national mourning while continuing to defend Operation Warp Speed, which funded Moderna’s dangerous and suspect vaccine, released on the market despite Big Pharma in Cambridge, Massachusetts, having known since 2019 that the new mRNA biotechnology could cause cancer…
Originally published on October, 6, 2025 – updated with VIDEO on August, 24, 2026
VIDEO – Two MASSIVE COVID shot studies on 8 MILLION people confirm that can trigger Turbo-Cancer in Vaccinated
Excerpt from American Thinker interview to American Epidemiologist Nicolas Hulscher
Korean Medical Doctors: “1-Year Cancer Risk Associated with COVID-19 Vaccination”
«The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data from 8,407,849individuals between 2021 and 2023 were obtained from the Korean National Health Insurance database».
We can read in the Abstract of the Korean study Kim et al. titled “1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea” which was conducted byHong Jin Kim (Department of Orthopedic Surgery, Kyung-in Regional Military Manpower Administration, Suwon) Min-Ho Kim (Informatization Department, Ewha Womans University Seoul Hospital, Seoul), Myeong Geun Choi and Eun Mi Chun (both in Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul).
The research was published on BMC Biomarker Research 13 (part of Springer Nature).
«The participants were categorized into two groups based on their COVID-19 vaccination status. The risks for overall cancer were assessed using multivariable Cox proportional hazards models, and data were expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). The HRs of thyroid (HR, 1.351; 95% CI, 1.206–1.514), gastric (HR, 1.335; 95% CI, 1.130–1.576), colorectal (HR, 1.283; 95% CI, 1.122–1.468), lung (HR, 1.533; 95% CI, 1.254–1.874), breast (HR, 1.197; 95% CI, 1.069–1.340), and prostate (HR, 1.687; 95% CI, 1.348–2.111) cancers significantly increased at 1 year post-vaccination» adds the Abstract.
«In terms of vaccine type, cDNA vaccines were associated with the increased risks of thyroid, gastric, colorectal, lung, and prostate cancers; mRNA vaccines were linked to the increased risks of thyroid, colorectal, lung, and breast cancers; and heterologous vaccination was related to the increased risks of thyroid and breast cancers. Given the observed associations between COVID-19 vaccination and cancer incidence by age, sex, and vaccine type, further research is needed to determine whether specific vaccination strategies may be optimal for populations in need of COVID-19 vaccination».
The Korean study indirectly confirms the warning raised by two Chinese universities in October 2020, even before the Covid-19 vaccines were released, regarding the very serious risks of lung disease that both mRNA and mDNA gene sera could cause.
Furthermore, the study found that booster doses were associated with significantly higher risks of gastric and pancreatic cancer. For pancreatic cancer, the risk more than doubled in booster recipients.
More details below inside the analysis of American epidemiologist Nicolas Hulscher.
Fabio Giuseppe Carlo Carisio – Gospa News director
BREAKING: Second Massive Population Study Finds COVID-19 “Vaccines” Increase Risk of 6 Major Cancers
Originally published by Nicolas Hulscher, MPH on Substack Focal Points – Courageous Discourse by McCullough Foundation
About a month ago, the first-ever population cohort study reported increased cancer risks following COVID-19 vaccination. In Italy, nearly 300,000 residents were tracked for 30 months, showing that mRNA shots significantly increased the risk of overall cancer, breast cancer, bladder cancer, and colorectal cancer
Now, a second—and far larger—population-based cohort study by Kim et al from South Korea has corroborated and expanded upon those findings. Drawing on a massive sample of more than 8.4 million people, this is one of the most powerful cancer-safety datasets ever analyzed.
The results are striking. After accounting for age, sex, comorbidities, income level, and prior COVID-19 infection, COVID-19 vaccination was linked to significant increases in multiple major cancers, with the signal consistent across all vaccine platforms, both sexes, and age groups:
Study Design at a Glance
Design & data: Population-based retrospective cohort using the Korean National Health Insurance database (2021–2023).
Population: 8,407,849 adults.
Exposure: COVID-19 vaccination (analyzed overall and by platform: mRNA, cDNA, and heterologous schedules).
Matching: Large-scale propensity score matching (1:4 vaccinated:unvaccinated for the main analysis; 1:2 within vaccinated for booster vs non-booster).
Modeling: Multivariable Cox proportional hazards models (adjusted for age, sex, comorbidity index, income level, and prior COVID-19 infection), estimating hazard ratios (HRs) with 95% confidence intervals (CIs); analyses stratified by sex and age.
Breast cancer: HR 1.20 (1.07–1.34) → 20% higher risk
Interpretation: An HR of 1.53 for lung cancer means that vaccinated individuals developed lung cancer at a rate 53% higher than matched unvaccinated peers, over the same one-year follow-up period. Similar interpretations apply to each cancer type.
Heterologous (mixed schedules): linked to higher risks of thyroid and breast cancers.
Overall cancer HR 1.34 (95% CI 1.21–1.48) → 34% higher risk
Interpretation: The elevated cancer risks were not confined to one vaccine platform. Whether adenoviral-vector (cDNA), mRNA, or mixed schedules, each vaccine type was associated with a measurable increase in overall cancer — and each had specific cancer sites driving the signal. In other words, no vaccine technology was free of cancer risk in this dataset.
Interpretation: Booster doses were associated with notably higher risks of gastric and pancreatic cancers. For pancreatic cancer, the risk more than doubled in boosted individuals.
Women: elevated risks for thyroid and colorectal cancers
Under 65 years: stronger signals for thyroid and breast cancers
≥75 years: markedly higher risk of prostate cancer
Interpretation: Both the overall and site-specific results show a consistent pattern — every demographic group experienced elevated cancer risks, though the type and absolute burden varied. Women and the elderly were hit hardest, but no population segment was spared.
Conclusions: Major Increases in Cancer Risk from Chortes Studies in Italy and South Korea.
Taken together, the evidence is now impossible to ignore. The only two population-level cohort studies ever conducted on COVID-19 vaccination and cancer — one in Italy and one in South Korea — have both found major increases in cancer risk.
The Italian study (≈300,000 people, 30-month follow-up) identified significant elevations in overall cancer, breast, bladder, and colorectal cancers. The South Korean study (8.4 million people, 1-year follow-up) confirmed and expanded these findings, documenting increased risks of overall cancer plus six site-specific cancers (lung, prostate, thyroid, gastric, colorectal, and breast).
Critically, the signal was observed across all vaccine types — both mRNA and viral-vector (cDNA) shots — and in every demographic group analyzed. In plain terms: both major COVID-19 vaccine platforms appear to be carcinogenic
With two independent national datasets converging on the same conclusion, governments, regulators, clinicians, and researchers must confront a sobering reality: nearly 70% of the global population has been injected with a carcinogenic product. The evidence demands immediate market withdrawal of these products.
At the McCullough Foundation, we are deeply investigating both the molecular mechanisms and the population-level data linking COVID-19 vaccination to cancer. We are currently preparing several new studies to expand this critical line of evidence.
This work requires substantial time, expertise, and resources, and we ask for your support in funding this urgent research: mcculloughfnd.org/products/donate-1
Oririnally published by Nicolas Hulscher, MPH on Substack Focal Points – Courageous Discourse by McCullough Foundation
Nicolas Hulscher, MPH – Epidemiologist and Foundation Administrator, McCullough Foundation
Login
